My New Normal

My New Normal


S2E7 | Serving Impact & Healing Our Hero’s with Dr. Kyle Bergquist

February 17, 2020

We're talking to Dr. Kyle Berquist, founder of Healing Our Hero's, co-founder of Serving Impact, author, and filmmaker.


Kyle is passionate about helping change the conversation around veteran suicide rates with Healing our Hero's and helping people understand imposter syndrome and how that affects our everyday lives.


In this episode we're talking about:



  • Imposter Syndrome and what it is
  • How Kyle's life was changed through working with veterans
  • The founding of Healing Our Hero's
  • Kyle's research around emotional healing through Ayahausca treatment
  • How to take your health into your own hands
  • The role of communication in building adaptive communities
  • The Race for Forever project and the effectiveness of bio-optimization
  • ... and so much more

Gifts from Partners



Classes Available



Courses Available



About Kyle


Dr. Kyle Bergquist DC co-created Serving Impact to help his fellow Chiropractors create the practice of their dreams. Kyle holds a B.S in Sports Medicine from Pepperdine University as well as a fellowship in Stem Cell Medicine from the American Academy of Anti-Aging and Regenerative Medicine.


Kyle founded and serves as the executive director for the Healing our Heroes' foundation, a 501c3 non-profit dedicated to helping veterans live their best life after service. Kyle served as the founder and CEO of the very successful Northwest Pain Relief.

Centers, integrated health care centers. At their pinnacle, they had 9 centers in 2 states.


Over the years Dr. Bergquist has started and run several successful clinics and knows first hand the real-life struggles that happen with each phase of growth and how to overcome them.


He has gone on to produce documentary films highlighting change-makers in the health and wellness space as well as veterans causes.

He is currently involved in the Race for Forever project to track bio-optimization data and show the efficacy to the masses.